Breakthrough COVID-19 cases and the game-changing Delta variant

What first responders need to know about the likelihood of side effects from the vaccine vs. the virus, plus new infection rates


Some people will get COVID-19 even if they are vaccinated. So what’s the point of getting the vaccine if you can still get the virus – deemed a “breakthrough infection”? The key: People who have been vaccinated are far less likely to contract COVID-19 than those who aren’t vaccinated. But there’s more to the story, particularly as it relates to side effects and how the Delta variant is changing the game.

First responders under the microscope

Doctors Jeff Burgess and Alberto Caban-Martinez are two well-known fire service researchers who are collaborating in a large prospective cohort of healthcare workers, first responders and others on the frontline of the pandemic to study the impact of the vaccine. The project – titled Healthcare, Emergency Response and Other Essential Workers Surveillance Study (HEROES); Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER) – has led to a national collaboration that is shedding light on the virus, vaccines, and their effectiveness among first responders.

While the initial COVID-19 variant (Alpha) has always been more contagious than the common flu – and with longer-term consequences for many – the Alpha variant’s rate of infectivity was 50% higher than the flu.
While the initial COVID-19 variant (Alpha) has always been more contagious than the common flu – and with longer-term consequences for many – the Alpha variant’s rate of infectivity was 50% higher than the flu. (Photo/Getty)

First, the study has found that less than 10% of individuals who have received both doses of an mRNA vaccine experienced a breakthrough infection.

The study also found that first responders in particular are at 60-100% higher risk of contracting the infection than healthcare workers. While data is still emerging, it seems that it is not patient/responder interactions that are driving the infection risk; rather, it is the communal living of the station or firehouse that is driving infection. While risk mitigation procedures are clear when treating patients, how to eliminate risk when you live with your colleagues one-third of the time – and ultimately share many of your exposures with them – is more of a challenge.

Vaccine side effect concerns

Still, concerns remain about the vaccine. Despite extensive research about the safety and efficacy of vaccines, there are still skeptics who point to the speedy rollout as a sign that they are not ready for use.

One example of concern is the recent warnings about Guillain-Barre syndrome in individuals who received the vaccination. It should be noted that this increased risk has been primarily a concern among adenovirus vector vaccines and has not been linked to mRNA vaccines, like the Moderna and Pfizer vaccines.

What often goes under-discussed is the risk of the side effects in comparison to the risk of the same outcome associated with COVID-19 infection. Specifically, while approximately 100 cases of Guillain-Barre syndrome are documented and under investigation among the 12 million vaccines given in the United States, the rate of Guillain-Barre syndrome among those infected with COVID-19 appears to be much higher. The same is true of nearly every side effect that has been raised as a concern related to the vaccines; this includes everything from fertility and impotence to cardiovascular complications – the rates of the side effects are actually higher among those infected with COVID-19 than those who received the vaccine.


Read more

Read more

Get vaccinated, win the ultimate prizes of good health and service to others

Receiving the COVID-19 vaccine is a safe and effective way to protect yourself, serve others and give back to your community


Game-changing Delta variant

With the initial variant of COVID-19, some argued that the risk of infection was not that high, so the risk of side effects from the vaccine was not worth the risk, given they believed they were not likely to contract the infection. Enter the Delta variant.

As of the writing of this article, 83% of cases in the United States are caused by the Delta variant – a staggering number considering that it was first identified in the U.S. in March 2021. While the initial COVID-19 variant (Alpha) has always been more contagious than the common flu – and with longer-term consequences for many – the Alpha variant’s rate of infectivity was 50% higher than the flu. The Delta variant’s rate of infectivity is 50% higher than the Alpha.

Given no vaccines and no attempts at mitigation, the average person infected with COVID-19 infected 2.5 additional people. The same situation with the Delta variant will lead to between 3.5 and 4 people being infected.

It’s not over

For those still deciding whether to get vaccinated, the choice is between risking the low chance of experiencing a side effect or the higher chance of experiencing the same issue as a symptom of infection.

So, what does this mean for the emergency services? Put simply, this pandemic isn’t over for us. The vaccine is providing some reprieve, but areas with high rates of vaccine deliberators are seeing significant increases in infection rates.

Another issue first responders needs to be aware of is that the Delta variant is infecting kids at a higher rate than previous variants. Researchers studying the viral load of the Delta variant compared to the original Alpha found the viral load was 1,000 times higher with the Delta variant. Given the infections occurring through communal living, first responders who are not vaccinated need to be aware of the risks posed to their families.

In all, the work is not finished for those on the front line. 

Stay safe and healthy. 


Read more

Read more

‘Long-COVID’: Understanding the long-term risks following a COVID-19 diagnosis

Regardless of case severity, many COVID-19 patients face serious persistent symptoms for months

Recommended for you

Join the discussion

Copyright © 2021 EMS1. All rights reserved.